NIH « Science and Enterprise

DNA Test Detects Early Bladder Cancer in Urine

By Alan, on May 2nd, 2023%

A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine

RSV Vaccine Breakthrough Examined at AAAS Meeting

By Alan, on March 5th, 2023%

As three vaccines against respiratory syncytial virus reach FDA review, a scientific conference explored a key breakthrough researchers achieved to get to this point. . . . → Read More: RSV Vaccine Breakthrough Examined at AAAS Meeting

Company-Academic Team to Test Vocal Indicators of Cognitive Decline

By Alan, on February 27th, 2023%

Researchers from a digital health company and academic medical center are beginning a pilot study of indicators in human voices for remote detection of mild cognitive decline. . . . → Read More: Company-Academic Team to Test Vocal Indicators of Cognitive Decline

NIH Award Funds A.I. to Detect Alzheimer’s in Clinical Notes

By Alan, on February 17th, 2023%

A small-business grant to a developer of natural language analytics for health care aims to detect evidence of cognitive decline from physicians’ notes in electronic health records. . . . → Read More: NIH Award Funds A.I. to Detect Alzheimer’s in Clinical Notes

Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

By Alan, on January 16th, 2023%

A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Project to Sequence 20K Dog and Cat Genomes

By Alan, on January 9th, 2023%

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

By Alan, on October 27th, 2022%

Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Nasal Spray Vaccines Get CEPI, NIH Funding

By Alan, on October 6th, 2022%

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

NIH Funds Decentralized Rare Disease Data Network

By Alan, on September 23rd, 2022%

A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network

Exec. Order Aims to Boost U.S. Biotech, Manufacturing

By Alan, on September 13th, 2022%

An executive order issued by President Joe Biden yesterday seeks to make biotechnology and biomanufacturing a centerpiece of the American economy. . . . → Read More: Exec. Order Aims to Boost U.S. Biotech, Manufacturing

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise